Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

Cumberland Pharmaceuticals v. Mylan Institutional LLC, No. 16-1155 (Fed. Cir. Jan. 26, 2017)

Affirmed
Invalidity (§ 102/§ 103) Infringement
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 16-1155
Also Docketed
No. 16-1259 (consolidated; same document)
Decided
January 26, 2017
Judge
Taranto, J.
Document
Precedential Opinion
Length
18 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Cumberland Pharmaceuticals, Inc. owns U.S. Patent No. 8,399,445, which describes and claims acetylcysteine compositions substantially free of chelating agents. It is listed in the Food and Drug Administration’s Approved Drug Products with Therapeutic Equivalence Evaluations (the Orange Book ) as covering Cumberland’s chelating - agent-free formulation of Acetadote ®, an intravenous antidote for ov erdoses of acetaminophen.

Download Opinion (PDF)

Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error